JUN 04, 2020 6:45 AM PDT

Tissue Stiffness Regulates Immune Responses

WRITTEN BY: Tara Fernandez

Cells are remarkably sensitive to the mechanical properties of their environment, changing their behavior as a result of physical forces exerted by the surrounding tissues. Over the last 20 years, scientists have uncovered that this phenomenon, known as mechanosensing, dictates a plethora of cellular responses, from cell division and differentiation to the activation of the immune system.

After a sprain, for example, joints swell and become stiff and mechanically rigid. How the physics of this tissue rigidity influences the dynamics of immune cells such as T and B lymphocytes, however, has remained unknown.

A team of researchers at UCLA may have found a missing piece of this puzzle: a molecule called yes-associated protein, or YAP. Through a series of experiments using genetically-modified mice, they found that T cells use YAP as a sensor of tissue rigidity, responding to these mechanical cues by either accelerating inflammation or hitting the brakes on it. 

The study’s senior author, Manish J. Butte explains, "In cases of both autoimmune activity and fighting off infection, YAP acts as an accelerator of the immune response in stiff tissues, and as a brake when there is mechanical softness." Specifically, YAP is able to access the metabolic control panel of T cells, flicking the switch for increased nutrient uptake to cope with a spike in energy requirements upon sensing tissue rigidity.

This new paradigm of immune system regulation has significant implications on future therapeutic strategies for diseases that have an immune component: autoimmune diseases, chronic infections, and some forms of cancer. 

"This is a whole new pathway that can be targeted to drive up immune responses in order to better fight infections, or slow down immune activity in conditions such as diabetes," said Butte. YAP-driven pathways are a prime target for potential drug targets and the subject of future research.

In follow up studies, Butte and colleagues plan to investigate whether YAP’s molecular pathways could be leveraged to treat mechanically rigid tumors, such as pancreatic and breast cancers. The team hypothesizes that YAP’s keen ability to sense tissue stiffness could be leveraged to amplify anti-tumor immune responses.


Sources: News Medical Life Sciences, Journal of Experimental Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 25, 2020
Immunology
The History of Vaccines
NOV 25, 2020
The History of Vaccines
Everyone worldwide is sitting with anticipation, waiting for the right vaccine candidate for the coronavirus outbreak, h ...
DEC 03, 2020
Immunology
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
DEC 03, 2020
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
Many of the life-threatening symptoms of COVID-19 have been pinned on “cytokine storms” — immune syste ...
JAN 05, 2021
Immunology
Immune Imbalances Dictate COVID Symptom Severity
JAN 05, 2021
Immune Imbalances Dictate COVID Symptom Severity
COVID symptoms. “As it is often the case for pathogenic infections, the host immune system is a key player in vira ...
JAN 26, 2021
Immunology
Can we Stop Multiple Sclerosis Progression?!
JAN 26, 2021
Can we Stop Multiple Sclerosis Progression?!
Multiple sclerosis is known for its progression of symptoms even after a period of complete remission. There is no way o ...
MAR 04, 2021
Immunology
Why Do We Need Two Shots of the COVID Vaccine?
MAR 04, 2021
Why Do We Need Two Shots of the COVID Vaccine?
Unlike social distancing, mask-wearing, and hand hygiene, vaccines are our best bet as a long-term solution to protectin ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
Loading Comments...